To underscore the clinical importance of these regulatory components, analysis of the TCGA dataset reveals that CFH and CFI expression are unfavorable prognostic markers in renal and urothelial cancers respectively (11), and several studies have identified CFH as a cancer biomarker (12–14). This evidence concerns the gene CFH and cancer.